On Monday, ProKidney Corp (NASDAQ: PROK) was 33.33% up from the session before settling in for the closing price of $2.04. A 52-week range for PROK has been $1.12 – $13.51.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -67.37%. With a float of $43.32 million, this company’s outstanding shares have now reached $59.88 million.
The firm has a total of 163 workers. Let’s measure their productivity.
ProKidney Corp (PROK) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward ProKidney Corp stocks. The insider ownership of ProKidney Corp is 29.70%, while institutional ownership is 57.33%. The most recent insider transaction that took place on Apr 16 ’24, was worth 43,095. In this transaction SVP of Regulatory Development of this company sold 17,238 shares at a rate of $2.50, taking the stock ownership to the 172,432 shares. Before that another transaction happened on Apr 12 ’24, when Company’s SVP of Regulatory Development sold 84,103 for $1.73, making the entire transaction worth $145,498. This insider now owns 189,670 shares in total.
ProKidney Corp (PROK) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -67.37% per share during the next fiscal year.
ProKidney Corp (NASDAQ: PROK) Trading Performance Indicators
You can see what ProKidney Corp (PROK) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 14.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.57, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of ProKidney Corp (PROK)
Analysing the last 5-days average volume posted by the [ProKidney Corp, PROK], we can find that recorded value of 2.07 million was better than the volume posted last year of 0.68 million. As of the previous 9 days, the stock’s Stochastic %D was 49.40%. Additionally, its Average True Range was 0.35.
During the past 100 days, ProKidney Corp’s (PROK) raw stochastic average was set at 70.32%, which indicates a significant increase from 66.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 204.44% in the past 14 days, which was higher than the 121.03% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.62, while its 200-day Moving Average is $4.12. Now, the first resistance to watch is $3.02. This is followed by the second major resistance level at $3.32. The third major resistance level sits at $3.83. If the price goes on to break the first support level at $2.21, it is likely to go to the next support level at $1.71. Now, if the price goes above the second support level, the third support stands at $1.41.
ProKidney Corp (NASDAQ: PROK) Key Stats
There are 229,344K outstanding shares of the company, which has a market capitalization of 167.61 million. As of now, sales total 0 K while income totals -35,470 K. Its latest quarter income was 0 K while its last quarter net income were -5,700 K.
